Aceragen, Inc. Common Stock (ACGN)

ACGN was delisted on the 21st of August, 2023.

• Market cap: $3.2M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.

Employees: 26